Ep0092 822 — Baltimore, Maryland

Ep0092 822 is a clinical research site located in Baltimore, Maryland, United States 21287.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0092 822 has participated in 1 clinical trials.

Therapeutic areas: Drug-Resistant Epilepsy, Focal-Onset Seizures.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0092 822?

Ep0092 822 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0092 822 conducted?

Ep0092 822 has 1 clinical trials on record. Their work covers Drug-Resistant Epilepsy, Focal-Onset Seizures.

Is Ep0092 822 accredited by Crixeo Health?

Ep0092 822 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0092 822?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.